Spontaneous autoimmune skin lesions of MRL/n mice: Autoimmune disease-prone genetic background in relation to Fas-defect MRL/lpr mice

Journal of Investigative Dermatology

Volumn 107, Issue 1, 1996, Pages 95-100

  Furukawa, Fukumi ^a   Kanauchi, Hideo ^b   Wakita, Hisashi ^a   Tokura, Yoshiki ^a   Tachibana, Takao ^b   Horiguchi, Yuji ^b   Imamura, Sadao ^b   Ozaki, Shouichi ^b   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Antinuclear antibody; Lupus erythematosus; Mixed connective tissue disease

Indexed keywords

FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GENE MUTATION; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; SKIN INFLAMMATION;

EID: 0030037447     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12298305     Document Type: Article

References (38)

1. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E: Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature (London) 271:67-69, 1978
2. Baart de la Faille-Kuyper EH: In-vivo nuclear localization of immunoglobulins in clinically normal skin in systemic and procainamide induced lupus erythematosus. Neth J Med 17:58-65, 1974
3. Berney T, Fulpius T, Shibata T, Reininger L, van Snick J, Weigert M, Marshak-Rothstein A, Izui S: Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol 4:93-99, 1992
4. Billings PB, Allen RW, Jensen FC, Hoch SO: Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity. J Immunol 128:1176-1180, 1982
5. Burrows NP, Bhogal BS, Jones RR, Black MM: Clinicopathologic significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J Cutaneous Pathol 20:159-162, 1993
6. David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LA: The clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99:251-257, 1992
7. Furukawa F, Ikai K, Matsuyoshi N, Shimizu K, Imamura S: Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes. J Invest Dermatol 101:191-195, 1993a
8. Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA: Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 94:77-85, 1990
9. Furukawa F, Lyon MB, Norris DA: Susceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol 52:460-472, 1989
10. Furukawa F, Maruyama N, Yoshida H, Hamashima Y, Hirose S, Shirai T: Genetic studies on the skin lupus band test in New Zealand mice. Clin Exp Immunol 59:146-152, 1985
11. Furukawa F, Ohshio G, Imamura S: Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp-+/+ mice. Arch Dermatol Res 285:20-26, 1993b
12. Furukawa F, Ohshio G, Tanaka H, Nakamura T, Ikehara S, Imamura S, Hamashima Y: Pathogenesis of lupus dermatoses in autoimmune mice. VI. correlation between positivity of lupus band test and lupus nephritis. Arch Dermatol Res 278:343-346, 1986
13. Furukawa F, Tanaka H, Sekita K, Nakamura T, Horiguchi Y, Hamashima Y: Dermatopathologic studies on skin lesions of MRL mice. Arch Dermatol Res 276:186-194, 1984
14. Galoppin L, Saurat JH: In vitro study of the binding of antiribonucleoprotein antibodies to the nucleus of isolated living keratinocytes. J Invest Dermatol 76:264-267, 1981
15. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
16. Gilliam JN, Prystowsky SD: Mixed connective tissue disease syndrome. Arch Dermatol 113:583-587, 1977
17. Horiguchi Y, Furukawa F, Hamashima Y, Imamura S: Ultrastructural lupus band test in skin of MRL/l mice. Arch Dermatol Res 278:474-480, 1986
18. Horiguchi Y, Furukawa F, Ohshio G, Horio T, Imamura S: Effects of ultraviolet light irradiation on the skin of MRL/l mice. Arch Dermatol Res 279:478-483, 1987
19. Kanauchi H, Furukawa F, Imamura S: Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol 96:478-483, 1991
20. Kondo S, Aso K: Establishment of a cell line of human skin squamous cell carcinoma in vitro. Br J Dermatol 105:125-132, 1981
21. Maruyama N, Furukawa F, Nakai Y, Sasaki Y, Obta K, Ozaki S, Hirose S, Shirai T: Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB × NZW) F1 hybrid and the correlation to renal disease. J Immunol 130:740-746, 1983
22. Murphy ED, Roths JB: Autoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Bigazzi PE, Warner NL (eds.). Genetic Control of Autoimmune Disease. Elsevier, New York, 1978, pp 207-221
23. Norris DA, Ryan SR, Fritz KA, Tan EM, Deng JS, Weston WL: The RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens. Clin Immunol Immunopathol 31:311-320, 1984
24. Okudaira K, Yoshizawa H, Williams R: Monoclonal murine anti-DNA antibody interacts with living mononuclear cells. Arthritis Rheum 30:669-678, 1987
25. Parks DR, Bryan VM, Oi VT, Herzenberg LA: Antigen specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci USA 76:1962-1965, 1979
26. Provost TT, Watson R: The MRL/lpr mouse model of cutaneous lupus. In: Wallace DJ, Hahn BH (eds.). Dubois' Lupus Erythematosus. 4th ed. Lea & Febiger, Philadelphia, 1993, pp 282
27. Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K: Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137-1141, 1993
28. Sharp GC, Irvin WS, Laroque RL, Velez C, Daly V, Kaiser AD, Holman HR: Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 50:350-359, 1971
29. Shirai T, Ohta K, Kohno A, Furukawa F, Yoshida H, Maruyama N, Hirose S: Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Arthritis Rheum 29:242-250, 1986
30. Shu S, Provost T, Croxdale MB, Reichlin M, Beutner EH: Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus. Clin Exp Immunol 27:238-244, 1977
31. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M: IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 147:515-519, 1991
32. Tamada Y, Takama H, Kitamura T, Yokochi K, Nitta Y, Ikeya T, Matsumoto Y: Identification of programmed cell death in normal human skin tissues by using specific labeling of fragmented DNA. Br J Dermatol 131:521-524, 1994
33. Tan EM, Kunkel HG: An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum 9:37-46, 1966
34. Theofilopoulos AN: The basis of autoimmunity: Part II, Genetic predisposition. Immunol Today 16:150-159, 1995
35. Theofilopoulos AN, Dixon FJ: Etiopathogenesis of murine SLE. Immunol Rev 55:179-216, 1981
36. Tuffanelli DL: Cutaneous immunopathology: recent observations. J Invest Dermatol 65:143-153, 1975
37. Velthuis PJ, Kater L, van der Tweel I, Meyling FG, Derksen RHWM, Hene RJ, van Gcutselaar JA, de la Faille HB: In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies. Ann Rheum Dis 49:163-167, 1990
38. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 356:314-317, 1992